Skip to main content
OpenTrials

Clinical trial condition

Monoclonal Gammopathy of Undetermined Significance

Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.

82 public trials 19 recruiting studies

Monoclonal Gammopathy of Undetermined Significance trial results

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States

NCT03616483

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States

NCT06895291

Conditions
Advanced Breast Cancer, Advanced Prostate Cancer, Blood Protein Disorders, +20 more
Locations
  • IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. Orsola Bologna, BO, Italy
  • IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l. Meldola, FC, Italy
  • IRCCS Istituto Europeo di Oncologia S.r.l. Milan, MI, Italy